LIVERPOOL, United Kingdom, Sept. 28, 2017 -- Liverpool Heart and Chest Hospital NHS Foundation Trust (LHCH), selected Allscripts (NASDAQ:MDRX) as its future partner for another five consecutive years with an expanded use of Sunrise suite of electronic patient record (EPR) solutions. The contract was signed in the second quarter of 2017.
Liverpool Heart and Chest Hospital provides specialist services in cardiothoracic surgery, cardiology, respiratory medicine including adult cystic fibrosis, and diagnostic imaging, both in the hospital and throughout the community. The Trust serves an area of 2.8 million people, spanning Merseyside, Cheshire, North Wales and the Isle of Man. LHCH first deployed the Sunrise suite of solutions in 2013 and is already paperless in most areas. Since EPR was deployed, the hospital has been rated one of the top Trusts for Clinical Digital Maturity Index (CDMI), a benchmarking tool that indicates the Trusts ability to effectively use information technology to improve patient safety and outcomes. LHCH is the first specialist Trust in the United Kingdom, Chesire and Merseyside to be rated as Outstanding by the Care Quality Commission.
“At LHCH, coordinated integration and interoperability via a common record with a single vendor is an important goal,” said Head of Digital Healthcare at LHCH, David Murphy. “We have had tremendous success with Sunrise and look forward to continuing to partner with Allscripts to remain at the forefront of digitally-enabled healthcare."
Allscripts Sunrise is a fully-integrated platform that supports all core care venues with a single platform and single patient record. The solution comprises functionality spanning investigation requests and results, clinical documentation, electronic prescribing and medicines administration to clinical decision support and workflow management. These features are used across inpatient and outpatient settings optimizing the delivery of safe and efficient care.
The use of Sunrise at LHCH has contributed to many benefits including supporting a sustained 63% reduction in hospital acquired pressure ulcers and enhanced infection control through standardized documentation and audit tools.
“Allscripts EPR improves patient safety when clinically checking a patient’s prescription as all the relevant clinical data is available to view from any terminal in the hospital,” said Senior Clinical Pharmacist at LHCH, Cassie Cordner.
“LHCH have optimized the Sunrise suite of solutions to deliver exceptional care on paperless wards,” said Vice President and Managing Director of Allscripts UK, Steve Brain. “I am delighted that LHCH re-committed to remain with Allscripts for another 5 years and to continue the strong partnership. We are committed to assisting LHCH with their mission to improve Quality and Patient Experience, supporting the Enhancement of Service Delivery, Research and Innovation to help drive their vision “to be the best – leading and delivering outstanding heart and chest care and research”.
About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2017 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
For more information contact:
Investors:
Seth Frank
312-506-1213
[email protected]
Media:
Concetta Rasiarmos
312-447-2466
[email protected]


Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Instagram Outage Disrupts Thousands of U.S. Users 



